Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity
- PMID: 32928982
- DOI: 10.1136/heartjnl-2020-318164
Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity
Keywords: cardiac procedures and therapy.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.Heart. 2020 Oct;106(19):1503-1511. doi: 10.1136/heartjnl-2020-317393. Epub 2020 Jul 31. Heart. 2020. PMID: 32737124 Free PMC article.
Similar articles
-
Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19.JAMA. 2020 Jul 14;324(2):177-178. doi: 10.1001/jama.2020.11401. JAMA. 2020. PMID: 32558905 No abstract available.
-
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.Hypertension. 2020 Aug;76(2):e15-e17. doi: 10.1161/HYPERTENSIONAHA.120.15622. Epub 2020 Jun 3. Hypertension. 2020. PMID: 32493070 No abstract available.
-
[Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].Kardiologiia. 2020 Apr 8;60(4):4-9. doi: 10.18087/cardio.2020.4.n1122. Kardiologiia. 2020. PMID: 32394850 Russian.
-
Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.Bol Med Hosp Infant Mex. 2020;77(5):274-281. doi: 10.24875/BMHIM.20000158. Bol Med Hosp Infant Mex. 2020. PMID: 33064690 Review. English.
-
Warum Adipöse so Covid-anfällig sind.MMW Fortschr Med. 2022 Nov;164(19):28-29. doi: 10.1007/s15006-022-2053-y. MMW Fortschr Med. 2022. PMID: 36310267 Free PMC article. Review. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources